Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · IEX Real-Time Price · USD
2.860
-0.140 (-4.66%)
At close: Jul 26, 2024, 2:58 PM
2.910
+0.050 (1.75%)
After-hours: Jul 26, 2024, 6:30 PM EDT
Armata Pharmaceuticals Revenue
Armata Pharmaceuticals had revenue of $966.00K in the quarter ending March 31, 2024, with 21.36% growth. This brings the company's revenue in the last twelve months to $4.70M, down -7.28% year-over-year. In the year 2023, Armata Pharmaceuticals had annual revenue of $4.53M, down -17.77%.
Revenue (ttm)
$4.70M
Revenue Growth
-7.28%
P/S Ratio
22.39
Revenue / Employee
$71,197
Employees
66
Market Cap
105.21M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Journey Medical | 80.00M |
Augmedix | 48.70M |
BrainsWay | 34.26M |
Omega Therapeutics | 4.94M |
I-Mab | 3.90M |
VistaGen Therapeutics | 1.06M |
Oramed Pharmaceuticals | 674.00K |
Cardiff Oncology | 610.00K |
ARMP News
- 15 days ago - Armata Pharmaceuticals Announces Completion of Enrollment of Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection - PRNewsWire
- 16 days ago - Armata Pharmaceuticals Announces Presentation at Viruses of Microbes 2024 - PRNewsWire
- 2 months ago - Armata Pharmaceuticals Announces First Quarter 2024 Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update - PRNewsWire
- 5 months ago - Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva - PRNewsWire
- 5 months ago - Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit - PRNewsWire
- 9 months ago - Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update - PRNewsWire
- 9 months ago - Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P.a. Clinical Study at the North American Cystic Fibrosis Conference - PRNewsWire